Eli Lilly's Mounjaro diabetes drug has demonstrated superior performance over Trulicity in reducing heart attack and stroke ...

Discover COMPASS Pathways' Q2 2025 progress: positive Phase III trial results, FDA engagement, and commercial readiness for COMP360 in ...

Quadrants has released its latest Smart Pills Startups/SMEs Companies Assessment, recognizing key players, including both ...

A tiny implantable heart device is changing lives for patients with HFpEF heart failure. Scripps La Jolla is among 65 ...

The key news from the release was that while the company outperformed revenue estimates—reporting $28.2 million (GAAP) compared to the expected $27.03 million—profitability came under pressure, with a ...

Vaping was sold as the antidote to smoking. However, for teens, it’s a deadly come-on. Fruity flavors mask toxins that scar ...

Detailed price information for Conduit Pharmaceuticals Inc (CDT-Q) from The Globe and Mail including charting and trades.